Patent details

Basic Information

Publication number:

EP2400018

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP110073293

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

In tumours differentially expressed gene products and use of the same.

French Title of Invention:

Produits géniques d'expression différentielle dans les tumeurs et leur utilisation

German Title of Invention:

Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung

SPC Number:

Dates

Filing date:

21/11/2003

Grant date:

04/05/2016

EP Publication Date:

04/05/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/12/2011

EP B1 Publication Date:

04/05/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/11/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/03/2020

 

 

Name:

Astellas Pharma Inc.

Address:

5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

History of Owners

From:

03/03/2020

To:

03/03/2020

Name:

Ganymed Pharmaceuticals GmbH

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

From:

21/11/2003

To:

03/03/2020

Name:

Ganymed Pharmaceuticals AG

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

04/07/2016

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Türeci Özlem

Address:

Germany (DE)

2

Name:

Sahin Ugur

Address:

Germany (DE)

3

Name:

Koslowski Michael

Address:

Germany (DE)

Priority

Priority Number:

10254601

Priority Date:

22/11/2002

Priority Country:

Germany (DE)

Classification

Main IPC Class:

C12N 15/11;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/05

Publication date:

09/04/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2020/05

Publication date:

09/04/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20200000066A

Date Registered:

03/03/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changement de forme juridique

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Ganymed Pharmaceuticals GmbH

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000067A

Date Registered:

03/03/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Astellas Pharma Inc.

Address:

5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

28/11/2022

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
03/03/2020	Request For Change	14
17/03/2020	Outgoing Correspondence	1
17/03/2020	Outgoing Correspondence	1
03/03/2020	Request For Change	14